Jump to: navigation, search
This image is provided by the National Library of Medicine.

WikiDoc Resources for Oxypertine


Most recent articles on Oxypertine

Most cited articles on Oxypertine

Review articles on Oxypertine

Articles on Oxypertine in N Eng J Med, Lancet, BMJ


Powerpoint slides on Oxypertine

Images of Oxypertine

Photos of Oxypertine

Podcasts & MP3s on Oxypertine

Videos on Oxypertine

Evidence Based Medicine

Cochrane Collaboration on Oxypertine

Bandolier on Oxypertine

TRIP on Oxypertine

Clinical Trials

Ongoing Trials on Oxypertine at Clinical Trials.gov

Trial results on Oxypertine

Clinical Trials on Oxypertine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Oxypertine

NICE Guidance on Oxypertine


FDA on Oxypertine

CDC on Oxypertine


Books on Oxypertine


Oxypertine in the news

Be alerted to news on Oxypertine

News trends on Oxypertine


Blogs on Oxypertine


Definitions of Oxypertine

Patient Resources / Community

Patient resources on Oxypertine

Discussion groups on Oxypertine

Patient Handouts on Oxypertine

Directions to Hospitals Treating Oxypertine

Risk calculators and risk factors for Oxypertine

Healthcare Provider Resources

Symptoms of Oxypertine

Causes & Risk Factors for Oxypertine

Diagnostic studies for Oxypertine

Treatment of Oxypertine

Continuing Medical Education (CME)

CME Programs on Oxypertine


Oxypertine en Espanol

Oxypertine en Francais


Oxypertine in the Marketplace

Patents on Oxypertine

Experimental / Informatics

List of terms related to Oxypertine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Oxypertine (Equipertine, Forit, Integrin, Lanturil, Lotawin, Opertil) is an antipsychotic used in the treatment of schizophrenia.[1] Chemically, it is an indole derivative similarly to molindone and a member of the phenylpiperazine class.[2] Like reserpine and tetrabenazine, oxypertine depletes catecholamines, though not serotonin, possibly underlying its neuroleptic efficacy.[3]

See also


  1. Hall, Chapman and; Rhodes, P. H (1996). Dictionary of organic compounds. London: Chapman & Hall. ISBN 0-412-54090-8.
  2. Breulet M, Labar P, Delree C, Collard J, Bobon J (February 1968). "[Oxypertine, peperazine derivative of tryptophan with neuroleptic and dynamogenic properties]". Acta Neurol Psychiatr Belg (in French). 68 (2): 116–27. PMID 4972600.
  3. Bak IJ, Hassler R, Kim JS (1969). "Differential monoamine depletion by oxypertine in nerve terminals. Granulated synaptic vesicles in relation to depletion of norepinephrine, dopamine and serotonin". Zeitschrift Für Zellforschung Und Mikroskopische Anatomie (Vienna, Austria : 1948). 101 (3): 448–62. PMID 5362847.